Cite
Tonix Pharmaceuticals Holding Corp. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Oct. 16, 2024)
MLA
“Tonix Pharmaceuticals Holding Corp. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Oct. 16, 2024).” Pharma Business Week, 28 Oct. 2024, p. 1446. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.813790606&authtype=sso&custid=ns315887.
APA
Tonix Pharmaceuticals Holding Corp. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Oct. 16, 2024). (2024, October 28). Pharma Business Week, 1446.
Chicago
Pharma Business Week. 2024. “Tonix Pharmaceuticals Holding Corp. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Oct. 16, 2024),” October 28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.813790606&authtype=sso&custid=ns315887.